Plasma and serum concentrations of VEGF-A121, but not of VEGF-A165, increase post-bevacizumab administration.
Okawa M, Yamakuchi M, Bibek A, Takenouchi K, Maywar DN, Yamada S, Inoue K, Higurashi K, Nakazawa J, Kawahira M, Kodama T, Tanoue K, Oyama Y, Higashi S, Fujisaki C, Hashinokuchi H, Tabaru A, Kanda H, Tachioka S, Imoto Y, Hashiguchi T, Soga Y.
Okawa M, et al. Among authors: tanoue k.
PLoS One. 2024 Dec 19;19(12):e0316035. doi: 10.1371/journal.pone.0316035. eCollection 2024.
PLoS One. 2024.
PMID: 39700124
Free PMC article.